XML 59 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Agreements (Details)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended 113 Months Ended 115 Months Ended 121 Months Ended
Sep. 30, 2019
USD ($)
Jul. 26, 2019
USD ($)
shares
Jan. 31, 2017
shares
Feb. 28, 2011
extension
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2016
USD ($)
Jun. 30, 2020
USD ($)
Aug. 20, 2020
USD ($)
Feb. 15, 2021
USD ($)
Oct. 31, 2019
USD ($)
Long-term Purchase Commitment [Line Items]                            
Total revenues         $ 1,402,000 $ 1,438,000 $ 2,643,000 $ 3,794,000            
BARDA                            
Long-term Purchase Commitment [Line Items]                            
Number of extension periods | extension       4                    
Total revenues         1,400,000 $ 1,400,000 2,600,000 $ 3,800,000     $ 72,600,000      
Cantex Pharmaceuticals Inc.                            
Long-term Purchase Commitment [Line Items]                            
Upfront cash payment for license and development agreement   $ 30,000,000.0                        
Shares issued for license and development agreement (in shares) | shares   10,000,000.0                        
Acquired in-process research and development   $ 65,000,000.0                        
Transaction costs   100,000                        
Payments to be made for regulatory milestones (up to)   202,500,000                        
Payments to be made upon achievement of specified net sales levels (up to)   $ 385,000,000.0                        
Royalty percentage to be paid (at least)   10.00%                        
SymBio Pharmaceuticals                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                 $ 5,000,000.0          
Termination notice period 90 days                          
Initial upfront payment to be received $ 5,000,000.0                         $ 5,000,000.0
Payment to be received upon achievement of milestones $ 180,000,000       $ 180,000,000.0   $ 180,000,000.0   $ 180,000,000.0   $ 180,000,000.0      
The Regents of the University of Michigan                            
Long-term Purchase Commitment [Line Items]                            
Upfront cash payment for license and development agreement                   $ 50,000        
Shares issued for license and development agreement (in shares) | shares     33,058                      
The Regents of the University of Michigan | Minimum                            
Long-term Purchase Commitment [Line Items]                            
Royalty percentage to be paid (at least)                   0.25%        
The Regents of the University of Michigan | Maximum                            
Long-term Purchase Commitment [Line Items]                            
Royalty percentage to be paid (at least)                   2.00%        
Scenario, Forecast | BARDA                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                         $ 78,900,000  
Scenario, Forecast | BARDA | Expense reimbursement                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                         75,800,000  
Scenario, Forecast | BARDA | Fees                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                         5,300,000  
Scenario, Forecast | BARDA Second Option Segment                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                       $ 23,900,000    
Scenario, Forecast | BARDA Third Option Segment                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                       $ 14,100,000    
Scenario, Forecast | BARDA Fourth Option Segment                            
Long-term Purchase Commitment [Line Items]                            
Total revenues                         $ 4,600,000